Develop and execute a global training strategy tailored to cell therapy programs across clinical and commercial stages.
Build role-specific onboarding, certification, and continuous learning pathways for Medical and Commercial field teams.
Deliver comprehensive training including disease state education, CAR T product design, clinical data, safety monitoring, and competitive landscape.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It is a scaling biotech environment with a culture driven by core values of collaboration, clarity, innovation, and ownership.
Implement a strategic engagement approach at defined accounts to ensure product coverage and access for a first-in-class gene therapy.
Collaborate cross-functionally with multiple departments and key stakeholders to drive product understanding and utilization.
Meet or exceed objectives by developing and implementing strategies specific to assigned accounts and payer relationships.
EVERSANA provides next-generation commercialization services to the life sciences industry, striving to create a healthier world. With a global team of over 6,000 employees serving more than 650 clients, we are committed to diversity and innovation.
Serve as the medical lead for LC-FAOD, MPS VII, and MPS IIIA, accountable for regional pull-through of global medical strategy and execution of US tactical plans.
Lead the UX111 US medical launch, partnering with Field Medical and Gene Therapy Treatment Teams to develop a robust launch plan.
Build and maintain strong relationships with KOLs, integrate insights into strategic planning, and lead collaborations on advisory boards and payer education.
Ultragenyx is a biopharmaceutical company committed to developing treatments for rare diseases. They foster a supportive and inclusive environment where employees can thrive both professionally and personally.
Support clinical trial recruitment and site outreach for the Duchenne program.
Establish and cultivate scientific relationships with KOLs in the Duchenne community.
Gather and share scientific insights to inform Medical Affairs strategies.
REGENXBIO is a biotechnology company focused on developing novel AAV gene therapies for patients with rare diseases. They are a growing company with a collaborative team and a culture built on trust, accountability, perseverance, and innovation.
Develop and execute a comprehensive global training strategy for cell therapy programs across clinical and commercial stages.
Build role-specific onboarding, certification, and continuous learning pathways for Medical, Commercial, and other teams.
Ensure training content complies with FDA, EMA, and global regulatory requirements while measuring competency and launch preparedness.
The company is a clinical-stage biotechnology organization developing innovative advanced therapies. It operates in a fast-paced, collaborative environment with a focus on launch readiness and cross-functional teamwork.
Serve as a subject matter expert in stem cell transplantation and cell therapy, fostering deep scientific relationships with key opinion leaders and healthcare providers.
Prepare and manage a territory plan, engage with field team members to support treatment center authorization and adverse event reporting.
Gather and communicate actionable scientific insights from congresses and stakeholder interactions to inform medical strategy and evidence generation.
Orca Bio is a commercial-stage biotechnology company developing next-generation cell therapies to improve outcomes for blood cancer patients undergoing stem cell transplants. It maintains a start-up culture of camaraderie, leadership by example, and a passion for science and compassion for patients.
Lead a team of UltraCare Liaisons to drive launch and commercialization of the neurology portfolio in the Great Lakes region.
Develop and execute regional business strategies, coaching field teams to achieve performance objectives and compliance.
Collaborate cross-functionally with Medical Affairs, Market Access, and other stakeholders to optimize patient access and business outcomes.
Ultragenyx is a biopharmaceutical company dedicated to developing life-changing treatments for rare diseases. They foster a supportive and inclusive culture focused on growth and learning.
Develop and execute US Medical Affairs strategy for evidence generation across tumor types, collaborating with internal and external stakeholders.
Provide strategic input into Global Integrated Strategic Plan and Plan of Action for ADC portfolio.
Prepare and present scientific data at internal meetings and external advisory boards.
Gilead is a biopharmaceutical company dedicated to advancing innovative medicines for life-threatening diseases like HIV, viral hepatitis, and cancer. With a global presence in over 35 countries, Gilead fosters a collaborative and inclusive culture focused on scientific excellence.
Identifies, establishes, and maintains collaborative relationships with key investigators and institutions in disease state areas of strategic focus.
Provides education to the medical community on the company’s investigational products and disease areas of focus.
Increases company visibility and enhances professional interaction with current and future oncology leaders.
Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, the company has a global team of over 100 employees headquartered in Boston, with a focus on advancing its lead asset, ficerafusp alfa.
Lead the development of disease-state and product-specific materials and the omni-channel scientific communications strategy.
Oversee the development of standard and custom responses to unsolicited requests and create internal Medical Information resources.
Lead publication strategy and execution for clinical and nonclinical data including manuscripts, abstracts, posters, and presentations.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities. The company is fully remote and headquartered in Radnor, Pennsylvania.
Develop and execute the Japan Medical Plan in close collaboration with the Executive Medical Director and global teams.
Partner with the local Field Medical team to enhance KOL engagement, identify speakers, and support clinical trial enrollment.
Provide balanced scientific and medical information through presentations, advisory boards, and feedback to internal stakeholders.
Ultragenyx is a biopharmaceutical company dedicated to developing treatments for rare diseases by challenging the status quo and creating a new model for patient care. The company fosters a supportive and inclusive culture focused on learning and growth, with a global team committed to making a meaningful impact.
You serve as the primary scientific interface between leading experts and Medical Affairs, facilitating scientific dialogue and generating insights.
You develop and execute a strategic regional engagement plan aligned with Immunic’s objectives and the competitive landscape.
You represent Immunic at national and regional scientific congresses and support development of scientific presentations.
Immunic Therapeutics is a biotechnology company focused on developing therapies for multiple sclerosis. The company is dedicated to advancing scientific understanding and responsible development of investigational therapies, fostering a diverse and inclusive workplace.